The Role of Timed Awakening in Treatment of Enuresis

Inclusion Criteria: * Our inclusion criteria are new and recently evaluated (within past 6 months) patients who are English-speaking * aged 6-17 * referred to the urology clinic for enuresis (Enuresis in our study is defined as nocturnal or diurnal enuresis (more than 1 bedwetting episode/week) for greater than 3 months) Exclusion Criteria: * Diagnosis of enuresis with comorbid diagnosis of diabetes mellitus (type 1 and 2), diabetes insipidus, chronic kidney disease, polyuria and/or polydipsia * Structural urologic disease (evaluated via baseline imaging) * Diagnosis of neurodevelopmental delays or conditions (i.e. celebral palsy, autism spectrum disorder) that hinders inability to follow age-appropriate instructions * Not potty trained * Improved or resolved enuresis for patients recently evaluated (within the past 6 months) * Non-English speaking * Patients currently on any over-active-bladder (OAB) medications (b3- agonists, antichloingerics) or alpha blockers for urinary symptoms (i.e. alfuzosin, tamsulosion, etc) or anti-diurectic medications for urinary symptoms (i.e.: desmopression (DDAVP)) * Patients currently using bed-wetting alarms * Patients and families who are actively seeing Pediatric Clinical Urologic Psychologist. * Inability or unwillingness of individual or legal guardian/representative to give written informed consent or participate in the study